http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2503143-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d31351c76b18378e315027a536c70e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
filingDate 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7a1f77ace0d2c496412b5458b36fb7
publicationDate 1982-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2503143-A1
titleOfInvention NOVEL PHENACYLAMINE DERIVATIVES, THEIR USE IN THERAPEUTICS AND THEIR PREPARATION METHOD
abstract THE PRESENT INVENTION RELATES AS NEW INDUSTRIAL PRODUCTS TO N- (2,4,6-TRIMETHOXYPHENACYL) -ALKYLAMINES OF THE FORMULA: (CF DRAWING IN BOPI) (OR R IS ISOPROPYL OR TERTIOBUTYL) AND THEIR ADDITIONAL SALTS. THESE NEW PRODUCTS ARE USEFUL THERAPEUTICALLY, ESPECIALLY AS SEDATIVE AND ANTIDEPRESSANT AGENTS OF THE CNS. THEY MAY BE PREPARED BY REACTION OF A 2,4,6-TRIMETHOXYPHENACYL HALOGENIDE WITH AN HNR AMINE.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2555576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143711-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143711-A2
priorityDate 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-1023815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1325192-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID202981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451431623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419644899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421332407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20263628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447931255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20263629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454062057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412370379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425963329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3069944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3069945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2447359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412370402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416147525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535237

Total number of triples: 55.